SEMA4D and atypical Rett syndrome: In this study, we demonstrated that anti-SEMA4D immunotherapy not only reverses Rett-like symptoms but also prevents them, however, the prevention of Rett syndrome neurological signs and symptoms remains challenging as diagnosis is mostly achieved after these neurological symptoms are evident.